Position in CELC
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$10,383,998
-$4,371,336 QoQ
Shares Held
90,976
-38.5% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 98.88871790362293.ToString("F0")%
None 1.1112820963770664.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,191,566,293 across 258 Biotechnology names. CELC ranks #55 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in CELC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,383,998 | 90,976 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $14,755,334 | 147,938 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $6,965,893 | 141,010 | Shares | Defined | 2025-11-13 | |
| 2024-03-31 | $4,219,235 | 195,335 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,048,437 | 209,227 | Shares | Defined | 2024-02-13 | |
| 2021-06-30 | $6,130,272 | 255,428 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||